Skip to main content

Vir Biotechnology, Inc 10-Q for FY2024 Q1

Vir Biotechnology, Inc. (VIR)

10-Q 2024-05-03 For: 2024-03-31
View Original
Added on April 09, 2026

About this 10-Q

Vir Biotechnology, Inc filed this 10-Q on May 3, 2024, covering the quarter ended March 31, 2024 (FY2024 Q1).

Headline figures

Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$56.38M
down 10.5% from $62.96M a year earlier
Net loss
$65.28M
compared with a net loss of $140.96M a year earlier
Diluted EPS
-$0.48
compared with -$1.06 a year earlier